Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis.

Jos Hendrikx, Marieke J de Jonge, Jaap Fransen, Wietske Kievit, Piet Lcm van Riel

Journal: RMD open 2016;2(2):e000202

PMID: 27651921

Plain Language Summary

plain language summary logo

Patient-reported outcome measures (PROMs) might offer a patient-friendly, location independent, time-efficient and cost-efficient means of monitoring chronic diseases such as rheumatoid arthritis. The objective of this study was to identify PROMs to assess disease activity in rheumatoid arthritis and to evaluate their measurement properties. The study is a systemic review which included 56 abstracts for full review of which 22 were excluded. In total 34 articles were included for full review This systematic review of PROM-based instruments identified 17 measures aimed at monitoring disease activity in rheumatoid arthritis. Authors conclude that the PROM-based tools for disease activity identified in the study may aid professionals in the choice of assessment in rheumatoid arthritis.

Abstract

Patient assessment of disease activity in rheumatoid arthritis (RA) may be useful in clinical practice, offering a patient-friendly, location independent, and a time-efficient and cost-efficient means of monitoring the disease. The objective of this study was to identify patient-reported outcome measures (PROMs) to assess disease activity in RA and to evaluate the measurement properties of these measures. Systematic literature searches were performed in the PubMed and EMBASE databases to identify articles reporting on clinimetric development or evaluation of PROM-based instruments to monitor disease activity in patients with RA. 2 reviewers independently selected articles for review and assessed their methodological quality based on the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) recommendations. A total of 424 abstracts were retrieved for review. Of these abstracts, 56 were selected for reviewing the full article and 34 articles, presenting 17 different PROMs, were finally included. Identified were: Rheumatoid Arthritis Disease Activity Index (RADAI), RADAI-5, Patient-based Disease Activity Score (PDAS) I & II, Patient-derived Disease Activity Score with 28-joint counts (Pt-DAS28), Patient-derived Simplified Disease Activity Index (Pt-SDAI), Global Arthritis Score (GAS), Patient Activity Score (PAS) I & II, Routine Assessment of Patient Index Data (RAPID) 2-5, Patient Reported Outcome-index (PRO-index) continuous (C) & majority (M), Patient Reported Outcome CLinical ARthritis Activity (PRO-CLARA). The quality of reports varied from poor to good. Typically 5 out of 10 clinimetric domains were covered in the validations of the different instruments. The quality and extent of clinimetric validation varied among PROMs of RA disease activity. The Pt-DAS28, RADAI, RADAI-5 and RAPID 3 had the strongest and most extensive validation. The measurement properties least reported and in need of more evidence were: reliability, measurement error, cross-cultural validity and interpretability of measures.

Address: Department of IQ Healthcare, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands; Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of IQ Healthcare , Radboud University Medical Center, Radboud Institute for Health Sciences , Nijmegen , The Netherlands.; Department of Rheumatology , Radboud University Medical Center , Nijmegen , The Netherlands.; Department for Health Evidence , Radboud University Medical Center, Radboud Institute for Health Sciences , Nijmegen , The Netherlands.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.